FDA has approved Eli Lilly’s GLP-1 drug Zepbound [tirzepatide] to treat moderate to severe obstructive sleep apnea in adults with obesity in combination with increased physical activity and a reduced-calorie diet.” https://t.co/rYiM6JzmDX https://t.co/hO6CgH9pVs
Links:
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for slee…
https://buff.ly/3ZZJhkw
Dec-30-2024
